Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma

NCT06160206 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Glioblastoma
Recurrent WHO Grade 4 Glioma

Interventions

BIOLOGICAL: Bevacizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
RADIATION: Hypofractionated Radiation Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Retifanlimab

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]